Weston Claire files initial ownership report at Gyre Therapeutics (GYRE)
Rhea-AI Filing Summary
GYRE THERAPEUTICS, INC. filed an initial Form 3 reporting the beneficial ownership status of director Weston Claire. The report lists Weston Claire as a director but shows no reported transactions or share holdings at this time. The remarks reference Exhibit 24, a Power of Attorney authorizing filings.
Positive
- None.
Negative
- None.
Key Figures
Buy transactions: 0
Sell transactions: 0
Holding entries: 0
+1 more
4 metrics
Buy transactions
0
Number of buy transactions reported for Weston Claire on this Form 3
Sell transactions
0
Number of sell transactions reported for Weston Claire on this Form 3
Holding entries
0
Total positions in GYRE stock or derivatives reported for Weston Claire
Net buy/sell shares
0
Net shares bought or sold by Weston Claire in this filing
Key Terms
Form 3, beneficial ownership, Power of Attorney, ten percent owner
4 terms
Form 3 regulatory
"filed an initial Form 3 reporting the beneficial ownership status"
Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.
beneficial ownership regulatory
"an initial Form 3 reporting the beneficial ownership status of director"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
Power of Attorney regulatory
"The remarks reference Exhibit 24, a Power of Attorney authorizing filings"
A power of attorney is a legal document that allows one person to make decisions and act on behalf of another person, often in financial or legal matters. It’s like giving someone a trusted helper or agent the authority to handle important tasks if you are unable to do so yourself. This matters to investors because it can impact how their assets are managed or transferred if they become unable to oversee their affairs.
ten percent owner regulatory
"is_ten_percent_owner set to 0 for the reporting person"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What does the Form 3 for GYRE show about Weston Claire?
The Form 3 reports that Weston Claire is a director of Gyre Therapeutics and currently shows no reported share holdings or insider transactions. It serves as an initial beneficial ownership statement required for certain insiders.
Does Weston Claire report any holdings of GYRE stock on this Form 3?
No holdings are reported. The filing indicates 0 holding entries, meaning no specific share positions are listed for Weston Claire in this initial beneficial ownership statement for Gyre Therapeutics.
Is there a Rule 10b5-1 trading plan mentioned in GYRE’s Form 3 for Weston Claire?
No. The Form 3 data show the Rule 10b5-1 indicator as null, and no footnotes describe a trading plan. The filing contains no statement that any trading plan applies to Weston Claire’s holdings.
What is the significance of the Power of Attorney in GYRE’s Form 3?
The remarks reference Exhibit 24 – Power of Attorney, which authorizes designated persons to sign and submit SEC ownership reports on Weston Claire’s behalf. It is an administrative tool to facilitate future Form 3, 4, or 5 filings.